KRAS and pancreatic neoplasm: We adopted this streamlined workflow to quantitatively detect gene alterations (i.e., Ewing sarcoma protein (EWS) gene rearrangements in Ewing sarcoma[16] and KRAS mutations in pancreatic cancer[17] patients.